Moreover, we determined that fluvoxamine may act as a potential repurposed drug to prevent motoneurons from insulting C9orf72-ALS through its selective role as a Sigma-1R agonist. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.